| Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control I Barbieri, K Tzelepis, L Pandolfini, J Shi, G Millán-Zambrano, SC Robson, ... Nature 552 (7683), 126-131, 2017 | 912 | 2017 |
| Role of RNA modifications in cancer I Barbieri, T Kouzarides Nature Reviews Cancer 20 (6), 303-322, 2020 | 753 | 2020 |
| METTL1 promotes let-7 MicroRNA processing via m7G methylation L Pandolfini, I Barbieri, AJ Bannister, A Hendrick, B Andrews, N Webster, ... Molecular cell 74 (6), 1278-1290. e9, 2019 | 348 | 2019 |
| RNA modifications detection by comparative Nanopore direct RNA sequencing A Leger, PP Amaral, L Pandolfini, C Capitanchik, F Capraro, V Miano, ... Nature communications 12 (1), 7198, 2021 | 269 | 2021 |
| Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten I Barbieri, S Pensa, T Pannellini, E Quaglino, D Maritano, M Demaria, ... Cancer research 70 (6), 2558-2567, 2010 | 171 | 2010 |
| Bromodomains as therapeutic targets in cancer I Barbieri, E Cannizzaro, MA Dawson Briefings in functional genomics 12 (3), 219-230, 2013 | 92 | 2013 |
| BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms BS Wyspiańska, AJ Bannister, I Barbieri, J Nangalia, A Godfrey, ... Leukemia 28 (1), 88-97, 2014 | 79 | 2014 |
| The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31 E Viré, C Curtis, V Davalos, A Git, S Robson, A Villanueva, A Vidal, ... Molecular cell 53 (5), 806-818, 2014 | 70 | 2014 |
| SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4 K Tzelepis, E De Braekeleer, D Aspris, I Barbieri, MS Vijayabaskar, ... Nature communications 9 (1), 5378, 2018 | 66 | 2018 |
| IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma N Prokoph, NA Probst, LC Lee, JM Monahan, JD Matthews, HC Liang, ... Blood, The Journal of the American Society of Hematology 136 (14), 1657-1669, 2020 | 44 | 2020 |
| Stat3 is required for anchorage‐independent growth and metastasis but not for mammary tumor development downstream of the ErbB‐2 oncogene I Barbieri, E Quaglino, D Maritano, T Pannellini, L Riera, F Cavallo, ... Molecular Carcinogenesis: Published in cooperation with the University of …, 2010 | 42 | 2010 |
| MicroRNAs-143 and-145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins L Avalle, D Incarnato, A Savino, M Gai, F Marino, S Pensa, I Barbieri, ... Cell Death & Differentiation 24 (10), 1750-1760, 2017 | 28 | 2017 |
| Controlled masking and targeted release of redox-cycling ortho-quinones via a C–C bond-cleaving 1,6-elimination L Dunsmore, CD Navo, J Becher, EG de Montes, A Guerreiro, E Hoyt, ... Nature Chemistry 14 (7), 754-765, 2022 | 21 | 2022 |
| Further evidence supporting N7-methylation of guanosine (m7G) in human microRNAs T Kouzarides, L Pandolfini, I Barbieri, AJ Bannister, B Andrews Molecular Cell 79 (2), 201-202, 2020 | 18 | 2020 |
| The non-coding epitranscriptome in cancer V Miano, A Codino, L Pandolfini, I Barbieri Briefings in functional genomics 20 (2), 94-105, 2021 | 12 | 2021 |
| From tissue invasion to glucose metabolism: the many aspects of signal transducer and activator of transcription 3 pro-oncogenic activities S Pensa, M Demaria, L Avalle, I Barbieri, A Camporeale, V Poli Hormone Molecular Biology and Clinical Investigation 10 (1), 217-225, 2012 | 2 | 2012 |
| Roles of non-coding RNAs in tumor growth and development G Sharma, I Barbieri, G Blandino, V Poli, JA Siddiqui Frontiers in Oncology 12, 1098315, 2022 | | 2022 |
| Evolution of cancer cell resistance versus intelligent design of epigenetic drugs I Barbieri, AJ Bannister Drug Discovery Today: Disease Models 12, 35-39, 2014 | | 2014 |
| STAT3 enhances migration and invasion in mammary tumor cells: a potential role for microRNAs-143 and-145 L Avalle, I Barbieri, S Pensa, P Provero, V Poli FEBS JOURNAL 278, 195-195, 2011 | | 2011 |
